Jennifer Harris

Jennifer Harris, PhD, serves as the Head of Research Policy at the Association of the British Pharmaceutical Industry (ABPI). In this role, she is responsible for shaping policies that impact clinical research and the pharmaceutical industry in the UK, focusing on enhancing patient access to new medicines and fostering innovation within the sector.

Educational Background

Dr. Harris holds a Bachelor of Science (BSc) and a Master of Philosophy (MPhil) from the University of Plymouth, as well as a PhD from the University of Cambridge, where she specialized in tumor immunology.13

Professional Experience

Before her current position at ABPI, Dr. Harris has worked in various capacities that bridge science and policy. Her work often involves data analysis, preparing reports for government officials, and engaging with pharmaceutical companies to understand their research and development initiatives. She plays a crucial role in addressing significant issues such as antimicrobial resistance and innovative clinical trials.12

Contributions to Policy and Research

Dr. Harris leads initiatives aimed at improving the UK's clinical research environment, particularly in light of challenges posed by the COVID-19 pandemic. She advocates for embedding clinical research within healthcare systems and works with government bodies to streamline regulatory processes for new treatments.2 Her efforts are integral to ensuring that the UK remains competitive in global pharmaceutical research and development.24

Personal Interests

Outside of her professional commitments, Dr. Harris has expressed a passion for medical science, politics, and current affairs, indicating a well-rounded engagement with both her professional field and broader societal issues.1

For more detailed insights into her work and contributions, you can find her LinkedIn profile under the username jennifer-harris-phd-78593783.3